A trial of transplanting Hepatitis C-viremic kidneys into Hepatitis C-Negative kidney recipients
Recruiting
99 years and younger
All
Phase
2
50 participants needed
1 Location
Brief description of study
The THINKER-NEXT research study is being done to determine whether it is safe to give a kidney transplant from a donor with hepatitis C to a patient without hepatitis C. The recipient will then be given a drug called Epclusa for 12 weeks to treat hepatitis C. Patients who are on the kidney transplant waitlist and do not have hepatitis C will be asked to participate.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Hepatitis C,renal
-
Age: - 99 Years
-
Gender: All
Updated on
01 Aug 2024.
Study ID: 842809
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
A copy of the message has been sent to your email
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
